
Ovid Therapeutics Hits New 52-Week High at $2.01, Marking Significant Milestone
2025-10-06 17:34:39Ovid Therapeutics, Inc. has achieved a new 52-week high of USD 2.01, recovering from a previous low of USD 0.24. Despite this milestone, the company has faced a challenging year with a significant performance decline. Ovid's market capitalization is USD 88 million, and it remains loss-making.
Read More
Ovid Therapeutics Hits New 52-Week High of $1.81, Marking Key Milestone
2025-09-29 14:22:46Ovid Therapeutics, Inc. has achieved a new 52-week high of USD 1.81, recovering from a low of USD 0.24. Despite this milestone, the company has faced a challenging year with a 44.19% decline in performance. Currently, it has a market capitalization of USD 88 million and is operating at a loss.
Read MoreNo announcement available
Corporate Actions
No corporate action available






